Schedule 13G ownership disclosure

X4 PHARMACEUTICALS INC

Security class unavailable · CUSIP: 98420X103

Event date: 2019-03-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
120,363
Percent of class
1.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000898432-19-000393
Form type
SC 13G
Filer
Bill & Melinda Gates Foundation
CIK
CIK 1663801
Filed
Mar 15, 2019
Reporting period
Mar 13, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub